ROME, Feb 3 (Reuters) - EssilorLuxottica said

on Monday it received a green light from the U.S. Food and Drug

Administration (FDA) for its over-the-counter Nuance audio

glasses.

Nuance - which pairs hearing solutions with prescription

glasses - will be available in the U.S. and in Italy in the

first quarter of the year and in other European countries,

including France, Germany and the UK, in the first half of 2025,

a statement said.

"We didn't just combine two medical devices, we created

entirely new smart glasses. It is not only groundbreaking, but

also incredibly accessible. We're pleased now to turn our focus

to getting this life-changing technology into the hands of

people," Chairman and CEO Francesco Milleri said.

With Nuance the company aims to reach around 1.25 billion

people worldwide who experience mild to moderate hearing loss,

the statement added.